Search 

Oppifi Oy was founded in 2007. The business idea of Oppifi is to develop, promote and sell services for storing and sharing memories the life stories.

The main product of Oppifi is a “recollection and life story” service Epooq. The service assists users to recall and tell stories with the help of digital storytelling; video, voice, photo and text. Stories can be shared to the relevant social networks – communities – by your own choise.

The chain that connects generations is built from different life stories. These stories include a wealth of personal experience, insight and learning about life and living. Life experience creates the meaning for human life.

Epooq is targeted especially for the grandparent generation, which has a lot of life experience and the need to store and share that. It was chosen a winner in the 2011 World Summit Award competition.

Epooq is sold as a service for
• Nursing homes guided groups
• Individual use active living at home

Contact Information
Oppifi Oy
Ilkka Tiainen
ilkka.tiainen@oppi.fi
www.oppi.fi

Project Tide is commercializing novel respiration measurement technology developed at Tampere University of Technology. The first application of this technology platform is in DIAGNOSIS AND MANAGEMENT OF CHILDHOOD ASTHMA.

Because of the very limited methods for objective lung function measurement in young children their diagnostic procedures for asthma are currently based on qualitative and subjective estimates of the symptoms. Approximately 15 % of all children exhibit symptoms before school age. There have been technological attempts to solve this widely acknowledged problem, but none have been successful so far. Our approach is paradigm changing and will globally affect the course of pediatric asthma diagnosis and management.

Our innovative system enables lung function measurements with practically no need of co-operation from the child. The measurement is done over one 24h period and analysed for signs of asthma in the respiratory flow pattern.

The technology is currently in clinical trial phase with the leading pediatric asthma research group in Finland. The first phase results on asthmatic preschool children are very encouraging and will be published soon.

We are seeking seed funding to establish a company in Q2 / 2014.

SuperECG has developed the HeartBug, an affordable and reliable ECG device for the consumers.

With the help of the SuperECG HeartBug and an online analysis service anyone can conduct a cardiac assessment that used to always require a visit to a clinic. The heartBug records the heart’s electrical activity for up to 24 hours and the advanced cardiac analysis system produces a report. The extensive report points out possible findings indicating arrhythmia, as well as the effect of physical exercise on cardiac rhythm.

The technology applied in the device and the analysis software has previously been developed by the parent company RemoteA for several years.

Sensire Oy is a Finnish technology company specialized in wireless measuring and sensoring, logistics tracking and analytics with secure and scalable Cloud-service.

Sensire TempNet® Pharma-product is usable in medical industry with environmental monitoring and logistics tracking with wireless sensors used in cargo boxes, reception/delivery terminals and vehicles, in hospitals or pharmaceutical factories.

Solution ensure medicine safety from production or warehouse to distribution in hospital or other eq. medical facilities. Additional sensors can measure environmental variables, like temperature & harmful particles. One feature is to monitor bio samples taken from patients and securing item transportation and conditions from doctor’s reception to laboratory room.

Sensire's Pharma-solution offers technological excellence and own IPR, proven concept of service, security and archive, expandability with connectivity and global user access expansion possibility.

Smartvisio care- and entertainment service runs on a cloud-based service platform which delivers communication and content services to the customers using standard audiovisual equipment – any standard TV and webcam are totally sufficient.   

Our mission is to encourage you and your family to take responsibility for your health and wellbeing. We do that by providing best-in-class online-service to organize and manage your and your family health and wellbeing information in one place and access it easily at your fingertips. We also support you to manage your or your love ones illnesses in the most effecient way.

The founder is Norwegian citizen living in Finland, a former NOKIA business director with 19 years experience in ICT and leadership. We have a great and energetic team including developers and advisors in health and wellbeing sectors in Finland and Scandinavia.

www.solarch.fi

We have started a Baltic Scandinavian elite accelerator for health science startups: AcceleraceLife. We are finishing our pilot round with 5 cases and present our/their success on Sept 26 in Tallinn. We have partners from 5 countries that will find and prepare best cases. The 10 cases to the accelerator will be chosen by the expert board in December 2013. At the moment we are finalising the model of the Nordic Baltic health tech fund. It is an evegreen model combinin convertible loans with upside.

TKS Technology A/S (TKS), a Danish registered limited company, specialized in developing and marketing wireless interface systems which create a whole new meaning to digital control, mobility and communication. 

Having spent 10 years and approx. EUR 2.5 million on research, development and testing by selected users TKS is now ready to bring the Itongue® product to market.

Itongue® is an intra-oral device which makes the user able to control devices with the tongue. The tongue is controlled directly by the brain - not through the spinal cord. Therefore Itongue® can be used by people suffering from severe paralysis not able to use traditional controllers. Furthermore, Itongue® does not only have a number of advantages compared to other applications, it simply takes controlling to the next generation. It is the only CE - certified control of its kind.

The intra-oral device is wirelessly connected to an external control unit which can be connected to control everything from computer keyboard and mouse to an electric wheelchair.

Based on the Itongue® platform TKS currently has planned 2 more innovative products in the pipeline. The first generation of Itongue® - now ready to be marketed - requires the user to get a tongue-piercing. The second generation – presently being developed - will not require a tongue piercing and will therefore be able to address a broader market such as surgeons, military jet pilots, gamers etc. Based on the current version of Itongue®. TKS is also developing a finger controlled version which is aimed at bringing better control capabilities to disabled who still have some movement capabilities in their fingers.

Having obtained a CE approval the Itongue® is now ready to be marketed as medical device in the EU.

Total global market which can be addressed by the Itongue® product is estimated to more than EUR 200 million annually with a split of approx. 40 per cent in Europe and 30 per cent in the US and with an expected growth rate of more than 100% per cent p.a.

Management of TKS expects to obtain some sales in 2013 and meet revenue objectives for 2014 of EUR 4 million, and in 2015 of EUR 10 million. Markets will be addressed through a combination of own sales force and external partners. Costumers for the first version of Itongue® are to be found among manufacturers of different types of medical devices e.g. wheelchairs.

The Company has now entered into a phase where the present owners and management are seeking a new owner / out-side co-investor who could add the required expertise and knowledge to commercialize the Company and its products - in other words to bring TKS and its products efficiently to the market; not only domestically but also in a number of international markets. An investment amount in the region of EUR 2 million is targeted in order to be able to full fill the business plan set up by the management of TKS. 

Basis organisation

Gert Spender, Exec. MBA, CEO 

Søren Mørch, M.Sc, development engineer (electronics) 

Jan Maltha, M.Sc. IT, development engineer (software) 

Poul Hansen, M.Sc. IT, development engineer (software) 

Hugo Bertelsen & Kirsten Berthelsen, interim technical project manager

Clinical trials partners and consultants

Lotte N.S. Andreasen Struijk, PhD (scientist and inventor), principal investigator 

Bo Bentsen (dentist) system encapsulation and materials

Dirk Leonhart (dental chief technician), Aarhus Dental College

Michael Gaihede, principal clinical investigator, Aalborg Hospital

Morten Haugland (reviewer), founder of Neurodan, currently scientific specialist of Medotech 

MediQA Consulting, Internal quality assurance and regulatory

DMD-Consulting, Poul Schmidt-Andersen, Managing Partner, B.Sc.E.E, B.Comm,

Compliance with EU and US regulatory requirements

Associated researchers

Lotte N.S. Andreasen Struijk, PhD, Associated Professor AAU

Fin Bering Sørensen, Professor dr. Med.

Eugen R. Lontis, PhD, development engineer (sensor technology design)

Hector A. Caltenco, PhD student (smart dictionary for the key pad)

Daniel Johansen, PhD student (SmartHand, control of hand prosthesis)

Brugerpanel (usergroup)